Summary
For Year 2026-27, Thyrocare Technologies reports the following shareholding: Total Promoters at 60.92%, Mutual Fund at 19.45%, Insurance at 0.37%, Foreign Institutional Investors at 5.37%, Domestic Institutional Investors at 1.17%, and Retail at 12.71%. This breakdown provides a quick snapshot of ownership distribution for Thyrocare Technologies in 2026-27.
Thyrocare Technologies FAQs
As of 04-2026, the promoter shareholding in Thyrocare Technologies stands at 60.92% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Thyrocare Technologies is 5.37% and 1.17% respectively.
The retail shareholding of the Thyrocare Technologies is 12.71%.
Changes in shareholding patterns of Thyrocare Technologies can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Thyrocare Technologies are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Thyrocare Technologies Associated Pages
- Thyrocare Technologies Share Price
- Thyrocare Technologies Share Price chart
- Thyrocare Technologies Fundamental Analysis
- Thyrocare Technologies Technical Analysis
- Thyrocare Technologies Peer Comparison
- Thyrocare Technologies Share Price History
- Thyrocare Technologies Dividend
- Thyrocare Technologies Bonus Share
- Thyrocare Technologies Board of Directors
